Education
About Us
Working with TipRanks
Follow Us
iX Biopharma Ltd. (SG:42C)
:42C
42C Stock Chart & Stats
S$0.08
>-S$0.01(-4.00%)
At close: 4:00 PM EST
S$0.08
>-S$0.01(-4.00%)
Day’s Range― - ―
52-Week RangeS$0.02 - S$0.14
Previous CloseN/A
Volume104.10K
Average Volume (3M)18.97M
Market Cap
S$104.88M
Enterprise ValueS$19.22M
Total Cash (Recent Filing)S$866.00K
Total Debt (Recent Filing)S$5.90M
Price to Earnings (P/E)―
Beta-0.04
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding888,843,400
10 Day Avg. Volume15,904,839
30 Day Avg. Volume18,966,432
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)38.32
Price to Sales (P/S)1.80
P/FCF Ratio-3.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
iX Biopharma Ltd. News
42C FAQ
What was iX Biopharma Ltd.’s price range in the past 12 months?
iX Biopharma Ltd. lowest share price was S$0.01 and its highest was S$0.14 in the past 12 months.
What is iX Biopharma Ltd.’s market cap?
iX Biopharma Ltd.’s market cap is S$104.88M.
When is iX Biopharma Ltd.’s upcoming earnings report date?
iX Biopharma Ltd.’s upcoming earnings report date is Feb 06, 2026 which is in 96 days.
How were iX Biopharma Ltd.’s earnings last quarter?
iX Biopharma Ltd. released its earnings results on Aug 29, 2025. The company reported -S$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.004.
Is iX Biopharma Ltd. overvalued?
According to Wall Street analysts iX Biopharma Ltd.’s price is currently Overvalued.
Does iX Biopharma Ltd. pay dividends?
iX Biopharma Ltd. does not currently pay dividends.
What is iX Biopharma Ltd.’s EPS estimate?
iX Biopharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iX Biopharma Ltd. have?
iX Biopharma Ltd. has 888,843,400 shares outstanding.
What happened to iX Biopharma Ltd.’s price movement after its last earnings report?
iX Biopharma Ltd. reported an EPS of -S$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of iX Biopharma Ltd.?
Currently, no hedge funds are holding shares in SG:42C
iX Biopharma Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
372.00%
12-Months-Change
Fundamentals
Return on Equity
-431.07%
Trailing 12-Months
Asset Growth
-22.84%
Trailing 12-Months
Company Description
iX Biopharma Ltd.
iX Biopharma Ltd. (42C) is a biopharmaceutical company based in Singapore that specializes in the development and commercialization of innovative therapeutics and drug delivery systems. The company primarily focuses on creating proprietary drug formulations that leverage its unique sublingual delivery technology, which enhances the bioavailability of various medications. iX Biopharma operates in the pharmaceutical sector and aims to address unmet medical needs in areas such as pain management, addiction, and other health conditions through its advanced product pipeline.
Technical Analysis
Hyphens Pharma International Ltd.
―
Pharmesis International Ltd.
―
Singapore Paincare Holdings Limited
―
Alliance Healthcare Group Ltd.
―
Beverly JCG Ltd.
―
Options Prices
Currently, No data available
---